Clinical Trial Details


Research Study Summary

Central Mechanisms that Regulate Glucose Metabolism in Humans


Doctors at Albert Einstein College of Medicine are seeking people aged 21-60, with Type 2 diabetes, who are otherwise healthy, to participate in a medical research study to better understand how diazoxide, an FDA approved blood pressure medication, can regulate the production of sugar by the liver.

Inclusion Criteria:

  • BP < 130/90 (+-2 meds)
  • BMI < 35
  • Normal screening labs (CBC, chemistry, lft's PT/PTT)
  • No CAD
  • No first degree relatives with history of CAD or MI (men < 45; women < 55)
  • Good IV access
  • No other medical problems with exception: HTN (on < or = 2 meds), hypercholesterolemia, and stable retinopathy
  • Non-smoker
  • Hemoglobin A1C 7.5-11

Exclusion Criteria:

  • BP>130/90 (+- medications)
  • BMI > 35
  • Abnormal EKG
  • History of CAD or exertional chest pain
  • First degree relative with early CAD or MI
  • Medications for medical or psychiatric conditions including: dofetilide, fosphenytoin/phenytoin trichlormethiazide (any thiazide), chlorpromazine and warfarin
  • < 4 week history of participation in another drug trial

To Learn more

CW ID:165047
Date Last Changed: October 13, 2014

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type


Morgan Drucker, Research Coordinator
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
Albert Einstein College of Medicine/Montefiore Medical Center
1300 Morris Park Avenue
Bronx, NY 10461
Phone: 718-430-2903

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.